Risk of Severe Hematologic Toxicities in Cancer Patients Treated With PARP Inhibitors: A Meta-Analysis of Randomized Controlled Trials

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s147726
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search